GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabist Company Holdings Inc (NEOE:CBST) » Definitions » EV-to-EBITDA

Cannabist Company Holdings (NEOE:CBST) EV-to-EBITDA : 30.76 (As of Jul. 19, 2025)


View and export this data going back to 2019. Start your Free Trial

What is Cannabist Company Holdings EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Cannabist Company Holdings's enterprise value is C$660.0 Mil. Cannabist Company Holdings's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 was C$21.5 Mil. Therefore, Cannabist Company Holdings's EV-to-EBITDA for today is 30.76.

The historical rank and industry rank for Cannabist Company Holdings's EV-to-EBITDA or its related term are showing as below:

NEOE:CBST' s EV-to-EBITDA Range Over the Past 10 Years
Min: -81.34   Med: -9.37   Max: 153.52
Current: 30.76

During the past 7 years, the highest EV-to-EBITDA of Cannabist Company Holdings was 153.52. The lowest was -81.34. And the median was -9.37.

NEOE:CBST's EV-to-EBITDA is ranked worse than
76.51% of 728 companies
in the Drug Manufacturers industry
Industry Median: 14.565 vs NEOE:CBST: 30.76

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2025-07-19), Cannabist Company Holdings's stock price is C$0.10. Cannabist Company Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was C$-0.317. Therefore, Cannabist Company Holdings's PE Ratio (TTM) for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Cannabist Company Holdings EV-to-EBITDA Historical Data

The historical data trend for Cannabist Company Holdings's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabist Company Holdings EV-to-EBITDA Chart

Cannabist Company Holdings Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-EBITDA
Get a 7-Day Free Trial -17.16 -21.61 93.55 16.12 16.42

Cannabist Company Holdings Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.28 11.46 5.72 16.42 31.29

Competitive Comparison of Cannabist Company Holdings's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabist Company Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cannabist Company Holdings's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabist Company Holdings's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Cannabist Company Holdings's EV-to-EBITDA falls into.


;
;

Cannabist Company Holdings EV-to-EBITDA Calculation

Cannabist Company Holdings's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=659.955/21.453
=30.76

Cannabist Company Holdings's current Enterprise Value is C$660.0 Mil.
Cannabist Company Holdings's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was C$21.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cannabist Company Holdings  (NEOE:CBST) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Cannabist Company Holdings's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.10/-0.317
=At Loss

Cannabist Company Holdings's share price for today is C$0.10.
Cannabist Company Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.317.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Cannabist Company Holdings EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Cannabist Company Holdings's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Cannabist Company Holdings Business Description

Traded in Other Exchanges
Address
321 Billerica Road, Suite 204, Chelmsford, MA, USA, 01824
Cannabist Company Holdings Inc through its subsidiaries, operates as a cultivator, manufacturer, and provider of medical and adult-use cannabis products. Some of its products are vaporization oil, sublingual tinctures, lotions, hard-pressed tablets, and suppositories, among others which are marketed through brands like Classix, dreamt, Triple Seven, Amber, Press, Heady, and Seed and Strain. The company operates its businesses in California, Colorado, Delaware, Illinois, Maryland, Massachusetts, New Jersey, New York, Ohio, Pennsylvania, Virginia, and West Virginia.
Executives
Bryan Lamont Olson Senior Officer
Jesse Channon Senior Officer
David Hart Senior Officer
Derek Alan Watson Senior Officer
David Sirolly Senior Officer
Julie Anne Hill Director
Jeffrey James Clarke Director
Alison Worthington Director
Nicholas Keane Vita 10% Security Holder, Director
Michael James Abbott 10% Security Holder, Director

Cannabist Company Holdings Headlines

No Headlines